Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?, Journal of Clinical Oncology, August 2015, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2014.60.6954.
You can read the full text:
Contributors
The following have contributed to this page
